A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer

Abstract Mebendazole is used extensively for treatment of local gut helminthic and invasive echinococcus infections. Anticancer effects of mebendazole have been shown in experimental cancer models and in case studies in patients with advanced cancer. Given these observations, the aims of this study...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: S. Mansoori, M. Fryknäs, C. Alvfors, A. Loskog, R. Larsson, P. Nygren
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/0e6899635f1f4dc08e23f090c9d52184
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!